Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analyses from the ENESTfreedom and ENESTop studies | Synapse
Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analyses from the ENESTfreedom and ENESTop studies
Key Points
The research aims to identify markers that can predict sustained remission without treatment in chronic myeloid leukemia patients.
Analyses of gene expression data from ENESTfreedom and ENESTop studies.
Evaluation of patient responses to treatment-free remission.
Statistical analysis to identify significant biomarkers.
Discovery of specific gene expression patterns associated with remission.
Identification of potential biomarkers that may guide treatment decisions.
Findings suggest that certain genes could predict long-term success without ongoing treatment.